facebook pixel
#NEWS: The U.S. FDA has approved our targeted therapy in combination with chemotherapy for patients with previously treated #NSCLC with specific EGFR mutations. Learn more here: t.co/xo3SRuiBaH #JNJOncology t.co/Yy3AVmQBvE
https://twitter.com/JNJInnovMed/status/1836910196116873718
Posted on Twitter/X ·

 7

 3

 1

 864

Credits
Suggested Credits

Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.

Tags, Events, and Projects